Dextroamphetamine Sulfate 5 mg/1 (Dextroamphetamine Sulfate TABLET) 5 mg/1

Dextroamphetamine sulfate acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from nerve terminals in the brain and inhibits their uptake. This leads to an increase in motor activity, causes euphoria, mental alertness and excitement, and suppresses appetite.

The usual dose of Dextroamphetamine Sulfate is determined by the prescribing physician based on the patient's condition, age, and response to treatment. It is important to follow the prescribed dosage and not to exceed it without medical advice.

Dextroamphetamine Sulfate is classified as a pregnancy category C drug, meaning it should be used during pregnancy only if the potential benefits outweigh the risks. It is not recommended for use during breastfeeding as it can pass into breast milk and may harm the nursing infant.

To order Dextroamphetamine Sulfate from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Dextroamphetamine Sulfate is a CNS stimulant that is effective in treating ADHD. It is compared to other stimulants like methylphenidate (Ritalin) and mixed amphetamine salts (Adderall). The choice of medication depends on individual patient response, side effect profile, and physician preference.

Dextroamphetamine Sulfate should be stored at room temperature between 20 and 25 degrees C (68 and 77 degrees F). Protect from light and moisture. Keep the container tightly closed. Proper storage ensures the medication's effectiveness and safety.

Dextroamphetamine Sulfate is administered orally, typically in the form of immediate-release tablets or an oral solution. The medication should be taken exactly as prescribed by the physician, usually once or twice a day, depending on the patient's needs and response.

The most serious risks associated with Dextroamphetamine Sulfate include cardiovascular events (sudden death, stroke, heart attack), psychosis (hallucinations, delusions), and new or worsening psychiatric symptoms (mania). Patients should be monitored closely for these risks, especially at the start of treatment or when the dose is increased.

Dextroamphetamine Sulfate should not be used by patients with known hypersensitivity to amphetamine products, those currently taking or within 14 days of stopping an MAOI, and those with certain cardiovascular conditions. It should be used with caution in patients with a history of drug abuse, cardiovascular disease, or elevated blood pressure.